Introduction
A secretor refers to a patient who secretes blood group antigens in fluids such as saliva, sweat, tears, semen, and serum. ABH refers to 'A' and 'B' antigens of ABO blood group and 'H' the heterogenic constituent of all ABO types including type 'O'. H antigen is the indirect gene product expressed as fucose-containing glycan unit and it resides on glycoproteins or glycolipids of erythrocyte membranes or on mucin glycoproteins in secretions. H antigen is expressed by two genes FUT1(H) gene predominantly in erythroid tissues; FUT2 (Secretor) gene is expressed predominantly in secretory tissues 1 .
Among all body fluids, saliva is the rich source to determine Secretor status 2 .
Saliva has protein, glycoprotein, peptide and carbohydrate constituents in addition to inorganic substances. Salivary glycoproteins are in constant interaction with variety of bacteria in the oral flora through their carbohydrate moiety. Fucosyltransferase 2 (FUT2) is responsible for fucosylation of glycoforms and this influences the scaffolding of Leb/y and blood type motifs. These glycans act as receptors mediating the adhesion of several bacteria in oral cavity, few examples including sT-Ag for Streptococcal strains and Le determinants for H. pylori strains. Fucosylation of gPRP disaccharide blocks bacterial binding. Nonsecretors have inactive form of FUT2 genotype and phenotype, thereby influencing salivary glycoproteins with significantly lower levels of fucosylation of the released N-glycans. Blood group and secretor status have significant influence in inter-individual variation in salivary glycosylation and consequently on interaction with bacterial milieu in the oral cavity 3 .
The ability or inability to secrete ABH blood group substances in body fluid has been studied with susceptibility to a number of pathological conditions. Previous studies have indicated that non-secretors are more prone to certain diseases such as autoimmune diseases like insulindependent diabetes mellitus 4 . Type II Diabetes mellitus (DM) is a metabolic disease which has a genetic predisposition, although environmental factors do play a significant role in its genetic expression. Like many other inherited traits, ABH secretor status is also genetically pre-determined and therefore we studied an association with diabetes mellitus and its complications.
Subjects and Methods
The study design was prospective analytical and the study group was recruited from the people who came for medical and surgical check-up in the outpatient department. Patients already diagnosed to have non-insulin dependent diabetes mellitus (NIDDM) were taken as study population (type II DM). Healthy individuals who are not diabetic (non-DM) were taken as healthy control from volunteers among health care workers in the hospital. Both males and females of age ranging from 18 to 74 years were recruited. A total of 198patients who had type II diabetes mellitus samples were subjected to secretor status identification from saliva samples. 200 healthy controls were recruited in the study and their secretor status from saliva was also determined. Ocular examination was performed and retinopathy was graded according to the modified Airlie House classification system. The moderate/severe diabetic retinopathy (DR) was defined as case: grade >=30; control: grade < 14. Physical findings as assessed by Physician were also documented in the study group. Patients who presented with symptoms of urinary tract infections were studied for routine urine examination with urine microscopy and culture and sensitivity. Majority of the patients in the study group (patients with type II diabetes mellitus) were not aware of the exact onset of the disease. Volunteers in the control group were also screened for blood pressure, urine albumin, sugar and microscopy and serum creatinine. Only those who were diagnosed in the hospital with records were included to avoid confounding factors. Ethical clearance was obtained from Institutional ethical committee. Chi-square test was performed to assess the statistical significance between the two variables. Sample collection and processing Collection of saliva was performed after thoroughly rinsing the mouth with water. All the saliva samples were collected 2-3 hours after the usual breakfast time. About 2ml of saliva was collected in a dry sterile tube. Saliva tube was kept for 20 minutes in a boiling water bath at 100⁰C to denature the salivary enzymes. It was then cooled to room temperature and centrifuged for 5 minutes at 1000g, supernatant was collected. Secretor status of the saliva samples were identified by using adsorption inhibition technique 13 . The procedure is briefly mentioned below. Six test tubes were labelled C, 2, 4, 8, 16, 32. C refers to the control tube, to which no saliva was added. 50 µl of saliva was added into the second tube labelled 2. For the rest of the tubes labelled 4, 8, 16 and 32, saliva was titrated by doubling dilution using normal saline. 50 µl of anti A serum was added to each test tube. All the tubes were shaken well and left undisturbed for 10-15 minutes. One drop of a suspension of group A RBCs in a concentration of 5% was added to each tube. The tubes were left to stand for 5 minutes and subsequently centrifuged at 3500 rpm for 20 seconds. The sediment was decanted on a slide and studied for presence of agglutination. (Fig 1) The degree of agglutination was graded as follows, Grade 0 -all red blood cells are discrete and evenly distributed in surrounding fluid (no agglutination) Grade 1 -Few or very occasional clumps Grade 2 -moderate aggregates Grade 3 -composed of moderate to large aggregates Grade 4-very large aggregates, very few cells remain free without agglutination. Control tubes always showed grade 4 Agglutination. The procedure was repeated with group B RBC and anti B serum and subsequently with group O RBCs and anti H serum. This is based on the principle that when saliva has blood group antigens, the antibodies in the serum of appropriate dilution will be utilized and will result in a negative agglutination when the corresponding blood group RBC's are added. Grades 0, 1, 2, 3 agglutination are interpreted as secretor while Grade 4 agglutination is interpreted as non-secretor. 2 ml of blood was collected in ethylene diamine tetra acetic acid (EDTA) coated vaccutainer tubes and ABO blood group and Rh typing was carried out by forward and reverse grouping techniques using test tube method as per standard operating procedure in the Institute. 2 ml of serum was collected from all the controls once and 2ml serum was collected from all the patients in both fasting and post-prandial state to assess the blood sugar levels (by Glucose oxidase-perioxidase method), serum creatinine by (Modified Jaffe's method), HbA1c (by Immuno-turbidometric method) and serum albumin (Bromocresol green dye binding method). Biochemical measurements were performed on fully authomated analyzer (Beckman Coulter) using colorimetric method. Urine examination was carried out for assessment of albuminuria (by Immuno-turbidometric method) and presence of sugar in urine by using strip test and subsequently urine was centrifuged and studied for deposits and casts by light microscopic examination. Each test was done in duplicate to ensure precision and accuracy and only concordant results were included for the analysis. 20 patients in the study population and 16 control samples had discordant results for secretor status assessment, which were excluded from the study. Duration of diabetes mellitus in the study population ranged from newly diagnosed patients to patients who had diabetes for more than 30 years. Clean catch mid stream urine is collected in a sterile wide mouthed container of capacity 50ml. Urine samples were inoculated in MacConkey agar and Blood agar using a sterile 4 mm platinum wired calibrated loop and incubated overnight at 37⁰C for 24 hours. The specimen was considered significant bacteriuria when the growth was > 10 5 colony forming unit (CFU/ml). The isolates were identified till species level using standard biochemical tests 14 The detailed split of the secretor status among various blood groups reflected that secretors were highest among O blood group followed by patients with A group. The picture was similar among study subjects and healthy control in the distribution of blood groups and secretors. However, non-secretors were found to be more common among study population in groups O, A and AB as highlighted in the table. (Table 2 ) Satterthwaite's degree of freedom = 389.531 Ha: diff < 0 Ha: diff = 0 Ha: diff > 0 Pr(T < t) = 0.00000 Pr(T > t) = 0.00000 Pr (T>t) = 1.0000 Pearson Chi Square test was performed within the study group (diabetes mellitus) for association of secretor status, duration of diabetes and various complications. Non-Secretor status is significantly associated culture positive urinary tract infection (p value = 0.005). Secretor status is significantly associated with hypertension (p value < 0.001). WBC casts were significantly associated with study group when compared with healthy control group (p value <0.001). Two sample t test with unequal variances was performed and the following parameters were found to be significant. Non-secretor status is significantly associated with increasing duration of diabetes (p value = 0.0176). Increased HbA1c level is significantly associated with both microalbuminuria, macroalbuminuria, retinopathy and neuropathy (p value < 0.001). Raise in HbA1c level is significantly associated with duration of diabetes (p value < 0.001, ANOVA, Barlett test for equal variances) and also with increase in serum creatinine (p value < 0 .001, ANOVA).
Fig 01 Discussion
Non-secretor status has been associated in the pathogenesis of diseases such as inflammatory bowel disease, rheumatic fever and increased predisposition to infections 16 .
Diabetic non-secretors appear to have lower levels of complement fractions when compared to diabetic secretors 17 . In our study, Non-secretors contributed to 66.5% in the healthy controls, while in patients with type II diabetes mellitus, 79% of the patients were non-secretors. Non-secretors constituted a much higher proportion in South Indian population when compared with Caucasian population 18 , where only 20% of the population were non-secretors. Our study results differ from a similar study in Pakistan19, where around 35% of their healthy population were non-secretors. The difference is significant as the method used is by adsorption-inhibition method in all the studies with serial dilutions. However, in a recent study from Bangladesh 20 , the non-secretor status ascertained by FUT2 genotyping status was 40%, these variations may be due to significant genetic variations across various geographic regions, thus highlighting the need to analyze this factor in greater detail. (Table  10 ) We also found significant increase in the percentage of non-secretors, constituting around 79% in the patients with type II diabetes mellitus. The increase in percentage of non-secretors in correlation with healthy controls was found to have strong statistical significance. On Univariate analysis between the healthy control group and the diabetes group, age, hypertension and secretor status were significantly associated. Multivariate analysis was performed with logistic regression and when adjusted for age, hypertension and blood group, secretors are nearly 2.1 times (110%) at higher odds of diabetes mellitus. WBC casts, age and hypertension were adjusted by logistic regression and secretors are nearly 2.4 times at higher odds of diabetes mellitus (odds ratio = 2.4). Thus, though nonsecretors appear to be predisposed to diabetes mellitus, when the data is analysed in comparison with healthy control and adjusted for confounding factors such as age and hypertension, secretors are at higher odds of developing diabetes mellitus. Our data is similar to the study by Smyth et al 21 ,
who found significant association of non-secretors with type I diabetes mellitus in a study design comprising of both healthy controls and study subjects.
In our study, we also found significant association of non-secretor status with duration of diabetes mellitus and culture positive UTI, while clinically suspected and UTI with positive WBC casts in urine did not show association. HbA1c levels were significantly associated with microangiopathic complications of diabetes mellitus which is similar to several other studies in the literature. Non-secretors were also common in the elderly. We could not find any report in the literature with this association. Possible heterozygous non-sense and frameshift mutations in FUT2 gene, which is a fetal gene involved in innate immunity may possibly be a reason for the same. However, the exact cause and effect association of age and nonsecretor status was not studied in this work.
Another interesting novel finding in the study was the significant association of hypertension with secretor status (p value<0.001). We did not find any literature with the association of secretor status and hypertension. The possible indirect association that we hypothesize is that gut microbiota is significantly associated with both systolic and diastolic hypertension 22 , and at the same time secretor status is proven to have significant role in the modulation of gut microbiome 12 . However, the direct cause and effect association of hypertension with secretor status needs further study. Association of type I diabetes has been reported with non-secretors earlier 21 . In our study too, if the analysis was confined only to the study group of patients with type II diabetes mellitus, nonsecretors had significant association with type II diabetes mellitus (p value = 0.006). However, on Cox multivariate regression analysis, after eliminating the potential confounders age and hypertension, secretor status was significantly associated with type II diabetes mellitus with over 110% higher odds (Odds ratio -2.1). In our study, non-secretor status was significantly associated with culture positive urinary tract infections and this was similar to the results from various other studies 23, 24 .All the patients with UTI included in our study group had lower urinary tract infection and we did not have any patients with pyelonephritis in our analysis.
Our results were however contradictory to the study by Smyth DJ et al 21 , who had described increased resistance to infection in association with non-secretors. We did not find any significant association of secretors with microvascular complications of type II diabetes mellitus. Raise in HbA1c levels showed significant association with retinopathy, neuropathy and diabetic nephropathy with increase in microalbuminuria, macroalbuminuria as well as serum creatinine levels (p value < 0.001). Our findings are similar to the findings from Ma et al 25 .
In our study, we did not carry out genotyping for various alleles of HbA1c but however in one of the earlier studies, genome wide association studies of the HbA1c locus could not show any association with complications of type II diabetes mellitus in Asian population 26 .
Another interesting observation that is highlighted in our study on multivariate analysis is the significant association of blood group B with secretor status. We could not get any literature on this association in the same population. However, in a study from Iraq, blood group O was found to be significantly associated with secretors 27 .
The major limitation in the study is the crosssectional nature of the study with lack of followup. However, the findings observed are novel and merit further attention and analysis in a larger population.
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